## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 1.7% below STRENGTH zone (3.0-6.0%); PEG 3.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Harvey Partners LLC Has $29.28 Million Stock Position in Rentokil Initial PLC $RTO**
- Source: MarketBeat | 20251214T124950 | Neutral | Relevance: 62%
- Harvey Partners LLC has reduced its stake in Rentokil Initial PLC by 25.7%, now holding 1.22 million shares valued at $29.28 million, making it their 13th largest holding. Conversely, other institutional investors like Bank of America have significantly increased their positions. Rentokil Initial currently holds a "Moderate Buy" consensus rating from analysts, with its stock trading around $28.67.

**2. III Capital Management Sells 45,000 Shares of Rentokil Initial PLC $RTO**
- Source: MarketBeat | 20251214T130936 | Neutral | Relevance: 60%
- III Capital Management reduced its stake in Rentokil Initial PLC by 28.7% in Q2, selling 45,000 shares and now holding 112,030 shares valued at $2.69 million. Despite this, other institutions like Bank of America significantly increased their holdings, and approximately 9.91% of the stock is owned by hedge funds and institutional investors. Analysts currently have a "Moderate Buy" consensus rating for RTO, with the stock trading around $28.67.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Barclays | $72 | $60 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($3295.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (6 transactions in 90 days).
2. Valuation stretched: PEG 3.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_10 improving +7.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.88 signals overvaluation risk, limited margin of safety. Forward P/E 46.9x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (1 raises, avg +20%). Insider selling cluster ($3295.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.9B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.88 |
| Forward P/E | 46.9 |
| Current P/E | 52.5 |
| YoY Growth | 12.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -5.2% to 1.7% (+7.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.3pp (needs >3.0% for momentum thesis). MRS_5 at 2.8% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 53. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.74% (CS: 45) | Neutral |
| RSI_14 | 53.1 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.061x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.02
- **Stop Loss:** $57.74 (3.8% risk)
- **Target:** $62.30 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 526
- **Position Value:** $31,570.52
- **Portfolio %:** 31.57%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*